• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OVCA1 通过降低细胞周期蛋白 D1 和增加 p16 抑制上皮性卵巢癌细胞的增殖。

OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.

机构信息

Department of Gynecology and Obstetrics, The First Affiliated Hospital, Dalian Medical University, Dalian, China.

出版信息

Mol Cell Biochem. 2011 Aug;354(1-2):199-205. doi: 10.1007/s11010-011-0819-0. Epub 2011 Apr 13.

DOI:10.1007/s11010-011-0819-0
PMID:21487939
Abstract

OVCA1, a tumor suppressor gene, is deleted or lower expressed in about 80% of ovarian cancer. Over expression of OVCA1 in human ovarian cancer A2780 cells inhibits cell proliferation and arrests cells in G1 stage. However, the fact that the molecular mechanism of OVCA1 inhibits cell growth is presently elusive. Here we investigated the potential signaling pathway induced by over-expression of OVCA1. Our results show that over-expression of human OVCA1 in ovarian cancer cells A2780 leads to down-regulation of cyclin D1, and up-regulation of p16, but no effect on the expression of NF-κB. It indicates that OVCA1 could inhibit the proliferation of ovarian cancer cell A2780 by p16/cyclin D1 pathway, but not by NF-κB.

摘要

OVCA1 是一种肿瘤抑制基因,约 80%的卵巢癌中存在 OVCA1 缺失或低表达。在人卵巢癌细胞 A2780 中过表达 OVCA1 可抑制细胞增殖并将细胞阻滞在 G1 期。然而,目前尚不清楚 OVCA1 抑制细胞生长的分子机制。在这里,我们研究了 OVCA1 过表达诱导的潜在信号通路。我们的结果表明,在卵巢癌细胞 A2780 中过表达人 OVCA1 导致细胞周期蛋白 D1 的下调和 p16 的上调,但对 NF-κB 的表达没有影响。这表明 OVCA1 可以通过 p16/细胞周期蛋白 D1 通路抑制卵巢癌细胞 A2780 的增殖,而不是通过 NF-κB。

相似文献

1
OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.OVCA1 通过降低细胞周期蛋白 D1 和增加 p16 抑制上皮性卵巢癌细胞的增殖。
Mol Cell Biochem. 2011 Aug;354(1-2):199-205. doi: 10.1007/s11010-011-0819-0. Epub 2011 Apr 13.
2
Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells.候选抑癌基因OVCA1在肿瘤中表达降低,并抑制卵巢癌细胞的生长。
Cancer Res. 1999 Oct 1;59(19):4973-83.
3
Anti-proliferation effects and molecular mechanisms of action of tetramethypyrazine on human SGC-7901 gastric carcinoma cells.川芎嗪对人SGC - 7901胃癌细胞的抗增殖作用及分子作用机制
Asian Pac J Cancer Prev. 2014;15(8):3581-6. doi: 10.7314/apjcp.2014.15.8.3581.
4
Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.溶血磷脂酸刺激人卵巢癌细胞的双重机制。
J Natl Cancer Inst. 2003 May 21;95(10):733-40. doi: 10.1093/jnci/95.10.733.
5
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.微小RNA-211通过靶向细胞周期蛋白D1和细胞周期蛋白依赖性激酶6抑制上皮性卵巢癌的增殖和细胞周期进程。
Mol Cancer. 2015 Mar 11;14:57. doi: 10.1186/s12943-015-0322-4.
6
Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.WWOX基因对人卵巢癌干细胞细胞周期调控及细胞凋亡的影响。
Mol Med Rep. 2015 Aug;12(2):1783-8. doi: 10.3892/mmr.2015.3640. Epub 2015 Apr 17.
7
OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.OVCA1在宫颈癌及上皮内瘤变中的表达及其与细胞周期蛋白D1和p16表达水平的相关性。
Oncol Lett. 2017 May;13(5):2929-2936. doi: 10.3892/ol.2017.5848. Epub 2017 Mar 13.
8
SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.SIRT1 在胃癌中表达下调,通过 NF-κB/Cyclin D1 信号通路导致 G1 期阻滞。
Mol Cancer Res. 2013 Dec;11(12):1497-507. doi: 10.1158/1541-7786.MCR-13-0214. Epub 2013 Oct 9.
9
RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.RN181 通过调控 ERK/MAPK-细胞周期蛋白 D1/CDK4 通路抑制胃癌细胞生长。
J Pathol. 2019 Jun;248(2):204-216. doi: 10.1002/path.5246. Epub 2019 Apr 11.
10
Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism.有证据表明,核因子(NF)-κB配体的受体激活剂可通过激活一种不依赖NF-κB且依赖TRAF6的机制来抑制细胞增殖并诱导细胞凋亡。
J Biol Chem. 2004 Feb 13;279(7):6065-76. doi: 10.1074/jbc.M308062200. Epub 2003 Nov 25.

引用本文的文献

1
Comparative analysis of the human serine hydrolase OVCA2 to the model serine hydrolase homolog FSH1 from S. cerevisiae.人源丝氨酸水解酶 OVCA2 与酿酒酵母模型丝氨酸水解酶同源物 FSH1 的比较分析。
PLoS One. 2020 Mar 17;15(3):e0230166. doi: 10.1371/journal.pone.0230166. eCollection 2020.
2
Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde.全基因组 CRISPR 筛选鉴定肿瘤抑制候选物 OVCA2 为乙醛耐受的决定因素。
Toxicol Sci. 2019 May 1;169(1):235-245. doi: 10.1093/toxsci/kfz037.
3
The tumor suppressor OVCA1 is a short half-life protein degraded by the ubiquitin-proteasome pathway.

本文引用的文献

1
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
2
Cell cycle, CDKs and cancer: a changing paradigm.细胞周期、细胞周期蛋白依赖性激酶与癌症:不断变化的范式
Nat Rev Cancer. 2009 Mar;9(3):153-66. doi: 10.1038/nrc2602.
3
Ovarian cancer.卵巢癌
肿瘤抑制因子OVCA1是一种通过泛素-蛋白酶体途径降解的半衰期较短的蛋白质。
Oncol Lett. 2019 Feb;17(2):2328-2334. doi: 10.3892/ol.2018.9852. Epub 2018 Dec 19.
4
Low-temperature Plasma Promotes Fibroblast Proliferation in Wound Healing by ROS-activated NF-κB Signaling Pathway.低温等离子体通过 ROS 激活的 NF-κB 信号通路促进伤口愈合中的成纤维细胞增殖。
Curr Med Sci. 2018 Feb;38(1):107-114. doi: 10.1007/s11596-018-1853-x. Epub 2018 Mar 15.
5
A mutated dph3 gene causes sensitivity of Schizosaccharomyces pombe cells to cytotoxic agents.一个突变的dph3基因会导致粟酒裂殖酵母细胞对细胞毒性剂敏感。
Curr Genet. 2017 Dec;63(6):1081-1091. doi: 10.1007/s00294-017-0711-x. Epub 2017 May 29.
6
OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.OVCA1在宫颈癌及上皮内瘤变中的表达及其与细胞周期蛋白D1和p16表达水平的相关性。
Oncol Lett. 2017 May;13(5):2929-2936. doi: 10.3892/ol.2017.5848. Epub 2017 Mar 13.
7
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.跨 14 种肿瘤类型的非编码体细胞突变和基因表达改变的系统分析。
Nat Genet. 2014 Dec;46(12):1258-63. doi: 10.1038/ng.3141. Epub 2014 Nov 10.
8
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.使用多平台分析鉴定出的1型神经纤维瘤病相关牛奶咖啡斑计数的遗传修饰因子。
PLoS Genet. 2014 Oct 16;10(10):e1004575. doi: 10.1371/journal.pgen.1004575. eCollection 2014 Oct.
9
The biosynthesis and biological function of diphthamide.二氢喋呤的生物合成和生物学功能。
Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):515-21. doi: 10.3109/10409238.2013.831023. Epub 2013 Aug 23.
Annu Rev Pathol. 2009;4:287-313. doi: 10.1146/annurev.pathol.4.110807.092246.
4
Alteration of cell-cycle regulation in epithelial ovarian cancer.上皮性卵巢癌中细胞周期调控的改变。
Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1169-82. doi: 10.1111/j.1525-1438.2008.01191.x. Epub 2008 Feb 19.
5
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.细胞周期蛋白D1作为癌基因的功能及细胞周期蛋白D1表达的调控。
Cancer Sci. 2007 May;98(5):629-35. doi: 10.1111/j.1349-7006.2007.00449.x. Epub 2007 Mar 14.
6
Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression.Notch1与NF-κB信号通路成分在人宫颈癌进展中的共表达
Gynecol Oncol. 2007 Feb;104(2):352-61. doi: 10.1016/j.ygyno.2006.08.054. Epub 2006 Nov 13.
7
The Akt pathway in human breast cancer: a tissue-array-based analysis.人类乳腺癌中的Akt信号通路:基于组织芯片的分析
Mod Pathol. 2006 Feb;19(2):238-45. doi: 10.1038/modpathol.3800525.
8
Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation.细胞周期抑制剂p21和p16是调节雪旺细胞增殖所必需的。
Glia. 2006 Jan 15;53(2):147-57. doi: 10.1002/glia.20263.
9
Pocket proteins and cell cycle control.口袋蛋白与细胞周期调控。
Oncogene. 2005 Apr 18;24(17):2796-809. doi: 10.1038/sj.onc.1208619.
10
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.p53 突变模式可区分卵巢浆液性交界性肿瘤以及低级别和高级别癌,并为卵巢癌发生的新模型提供支持:一项免疫组化相关性突变分析
Am J Surg Pathol. 2005 Feb;29(2):218-24. doi: 10.1097/01.pas.0000146025.91953.8d.